CIBC Asset Management
RVMD icon

CIBC Asset Management’s Revolution Medicines RVMD Stock Holding History

CIBC Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Buy
8,768
+492
+6% +$71.9K ﹤0.01% 671
2026
Q1 		$805K Buy
8,276
+2,238
+37% +$226K ﹤0.01% 725
2025
Q4 		$481K Buy
6,038
+917
+18% +$60.1K ﹤0.01% 810
2025
Q3 		$239K Buy
+5,121
New +$201K ﹤0.01% 1054
2025
Q1 		– Sell
-5,037
Closed -$220K – 1234
2024
Q4 		$220K Buy
5,037
+270
+6% +$13.6K ﹤0.01% 1064
2024
Q3 		$216K Buy
+4,767
New +$208K ﹤0.01% 1061

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

CIBC Asset Management's RVMD Position: Q2 2026 in Review

CIBC Asset Management increased its Revolution Medicines (RVMD) stake by 5.9% in Q2 2026, buying an estimated $71.9K and bringing the position to 8,768 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #671.

CIBC Asset Management first reported a position in RVMD in Q3 2024 and has held it in 6 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • CIBC Asset Management held 8,768 shares of Revolution Medicines worth $1.64M as of Q2 2026.
  • CIBC Asset Management bought 492 Revolution Medicines shares in Q2 2026, an estimated $71.9K.
  • Revolution Medicines made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #671 holding.
  • CIBC Asset Management first reported a position in Revolution Medicines in Q3 2024 and has held it in 6 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.